Prophylactic effect of neuroleptics in symptom-free schizophrenics: A comparative dose-response study of haloperidol and propericiazine

Psychopharmacology

Volumn 82, Issue 3, 1984, Pages 153-156

  Nishikawa, Tadashi ^a   Tsuda, Akira ^a   Tanaka, Masatoshi ^a   Hoaki, Yoshio ^a   Koga, Itsuyuki ^b   Uchida, Yasunori ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Seiwakai Nishikawa Hospital   (Japan)

Author keywords

Haloperidol; Prolactin; Propericiazine; Prophylactic effect; Schizophrenics in remission

Indexed keywords

HALOPERIDOL; PERICIAZINE; PROLACTIN;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; DRUG THERAPY; HUMAN; PROPHYLAXIS; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; THERAPY;

ADULT; ANALYSIS OF VARIANCE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PHENOTHIAZINES; RANDOM ALLOCATION; SCHIZOPHRENIA;

EID: 0021360392     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00427763     Document Type: Article

References (19)

1. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
2. Schizophrenics fully remitted on neuroleptics for 3–5 years. —To stop or continue drugs?
3. Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process
4. Overview: Maintenance therapy in psychiatry. I. Schizophrenia
5. Plasma levels of antipsychotic drugs and clinical response
6. Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization —A reevaluation
7. Schizophrenia: A theory
8. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: Double-blind placebo trial
9. Low-dose neuroleptics in outpatient schizophrenics
10. Amphetamine-induced dopaminergic hypersensitivity in guinea pigs: Implications in psychosis and human movement disorders
11. Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses
12. Trial of maintenance therapy in schizophrenia
13. Effect of neuroleptics on serum prolactin levels in relation to clinical response and neuroleptic blood levels
14. Prophylactic effect of neuroleptics in symtom-free schizophrenics
15. Biochemical research into psychosis
16. Drugs, neurotransmitters, and schizophrenia
17. Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine
18. Maintenance phenothiazines in aftercare of schizophrenic patients
19. A trial on follow-up in outpatients with psychosis using the computer system —Analysis of social adjustment levels and regularity of consultation and/or prescription